Pages that link to "Q74469807"

The following pages link to Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma (Q74469807):

Displaying 29 items.

• Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944) (Q28270514) (← links)
• Imaging in evaluation of response to neoadjuvant breast cancer treatment (Q28271650) (← links)
• Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer (Q33620136) (← links)
• Study of tumour cellularity in locally advanced breast carcinoma on neo-adjuvant chemotherapy (Q33783622) (← links)
• Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657). (Q33913615) (← links)
• Utility of FDG-PET/CT in the evaluation of the response of locally advanced breast cancer to neoadjuvant chemotherapy (Q33966252) (← links)
• The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET (Q34048123) (← links)
• Dose-intensive chemotherapy for locally advanced breast cancer (Q34107649) (← links)
• Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial (Q34117012) (← links)
• Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer (Q34138733) (← links)
• PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake. (Q34914187) (← links)
• Locally advanced breast cancer in developing countries: the place of surgery (Q35144241) (← links)
• Pre-operative systemic therapy in locally advanced breast cancer: a single institution experience. (Q35572926) (← links)
• Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations (Q35753798) (← links)
• FDG-PET in monitoring therapy of breast cancer (Q35757773) (← links)
• Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer (Q36621469) (← links)
• Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer (Q36623843) (← links)
• Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer? (Q36671085) (← links)
• Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer (Q37121648) (← links)
• Impact of grade, hormone receptor, and HER-2 status in women with breast cancer on response to specific chemotherapeutic agents by in vitro adenosine triphosphate-based chemotherapy response assay (Q37417973) (← links)
• Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer (Q40362934) (← links)
• FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients (Q42940980) (← links)
• Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience. (Q45986612) (← links)
• Epirubicin, cyclophosphamide and weekly paclitaxel as neoadjuvant chemotherapy for stage II and III breast cancer (Q46910545) (← links)
• Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer. (Q49378717) (← links)
• Increased efficacy of a dose-dense regimen of neoadjuvant chemotherapy in breast carcinoma: a retrospective analysis. (Q54525386) (← links)
• Locally advanced breast cancer (Q74267179) (← links)
• [Morphological response to therapy of breast carcinoma] (Q80477059) (← links)
• [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy (Q80501660) (← links)